
Shares of Amgen AMGN.O up 1.7% at $343.99 in after-hours trading
AMGN reports quarterly revenue rises 9% from a year earlier to $9.9 billion, beating the average analyst estimate of $9.5 billion, according to LSEG data
It posts Q4 adjusted earnings per share at $5.29, exceeding analysts' expectations of $4.73
Amgen expects 2026 adjusted earnings per share of $21.60 to $23.00, while Wall Street estimates it to be $22.09 per share
Co forecast annual revenue to be in the range of $37 billion to $38.4 billion, with a midpoint well ahead of analysts' forecast of $37.1 billion
Stock has been up 3.5% in 2025